Cargando…

Inhibition Lysosomal Degradation of Clusterin by Protein Kinase D3 Promotes Triple‐Negative Breast Cancer Tumor Growth

Triple negative breast cancer (TNBC), with its lack of targeted therapies, shows the worst mortality rate among all breast cancer subtypes. Clusterin (CLU) is implicated to play important oncogenic roles in cancer via promoting various downstream oncogenic pathways. Here, protein kinase D3 (PRKD3) i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yan, Zhou, Yehui, Ma, Xinxing, Chen, Liming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Full Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887572/ https://www.ncbi.nlm.nih.gov/pubmed/33643800 http://dx.doi.org/10.1002/advs.202003205

Ejemplares similares

Protein Kinase D3 promotes the cell proliferation by activating the ERK1/c‐MYC axis in breast cancer
por: Liu, Yan, et al.
Publicado: (2020)

Association of HDAC8 Expression with Pathological Findings in Triple Negative and Non-Triple Negative Breast Cancer: Implications for Diagnosis
por: Menbari, Mohammad-Nazir, et al.
Publicado: (2020)

The oncogenic role of protein kinase D3 in cancer
por: Liu, Yan, et al.
Publicado: (2021)

Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4/6 inhibition
por: Fassl, Anne, et al.
Publicado: (2020)

Triple Negative Breast Cancer is Dependent on the Lysosomal Cholesterol Transporter NPC1
por: O’Neill, Kathleen
Publicado: (2021)

Heparan sulfate and clusterin: Cleaning squad for extracellular protein degradation
por: Sánchez-Martín, Pablo, et al.
Publicado: (2020)

Brassinin Promotes the Degradation of Tie2 and FGFR1 in Endothelial Cells and Inhibits Triple-Negative Breast Cancer Angiogenesis
por: Gu, Yuan, et al.
Publicado: (2022)

O-GlcNAcylation promotes tumor immune evasion by inhibiting PD-L1 lysosomal degradation
por: Zhu, Qiang, et al.
Publicado: (2023)

Prevention of Dominant IgG Adsorption on Nanocarriers in IgG‐Enriched Blood Plasma by Clusterin Precoating
por: Prozeller, Domenik, et al.
Publicado: (2019)

Design of a Novel Recombinant Multi-Epitope Vaccine against Triple-Negative Breast Cancer
por: Dariushnejad, Hassan, et al.
Publicado: (2022)

Dipalmitoylphosphatidic acid inhibits tumor growth in triple-negative breast cancer
por: Zhang, Qian-Qian, et al.
Publicado: (2017)

Knockdown of SPON2 inhibits the growth of triple-negative breast cancer
por: Hu, Xueyi, et al.
Publicado: (2023)

Rutaecarpine induces the differentiation of triple-negative breast cancer cells through inhibiting fumarate hydratase
por: Lei, Jie, et al.
Publicado: (2023)

Phytochemicals inhibit migration of triple negative breast cancer cells by targeting kinase signaling
por: Shahi Thakuri, Pradip, et al.
Publicado: (2020)

Glycogen synthase kinase-3β inhibition promotes lysosome-dependent degradation of c-FLIP(L) in hepatocellular carcinoma
por: Zhang, Na, et al.
Publicado: (2018)

JAG1 enhances angiogenesis in triple-negative breast cancer through promoting the secretion of exosomal lncRNA MALAT1
por: Liu, Junping, et al.
Publicado: (2022)

ERβ inhibits cyclin dependent kinases 1 and 7 in triple negative breast cancer
por: Reese, Jordan M., et al.
Publicado: (2017)

The oncogenic miR-429 promotes triple-negative breast cancer progression by degrading DLC1
por: Li, Yao, et al.
Publicado: (2023)

Modeling Heterogeneity of Triple‐Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance
por: Lamballe, Fabienne, et al.
Publicado: (2020)

A photodynamic-mediated glutamine metabolic intervention nanodrug for triple negative breast cancer therapy
por: Yu, Cancan, et al.
Publicado: (2023)

Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin B1 expression and tumor growth in triple negative breast cancer
por: Rajput, Sandeep, et al.
Publicado: (2016)

Hypoxia Inducible Factor-1α Directly Regulates Nuclear Clusterin Transcription by Interacting with Hypoxia Response Elements in the Clusterin Promoter
por: Park, Jeongsook, et al.
Publicado: (2014)

MiR-940 Inhibited Cell Growth and Migration in Triple-Negative Breast Cancer
por: Hou, Lingmi, et al.
Publicado: (2016)

Rapid Synthesis of N‐Tosylhydrazones under Solvent‐Free Conditions and Their Potential Application Against Human Triple‐Negative Breast Cancer
por: Xie, Zengyang, et al.
Publicado: (2018)

Protein kinase C inhibitor chelerythrine selectively inhibits proliferation of triple-negative breast cancer cells
por: Lin, Wanjun, et al.
Publicado: (2017)

Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer
por: He, Jichao, et al.
Publicado: (2019)

Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer
por: Giordano, Antonio, et al.
Publicado: (2019)

Aurora Kinase A and Bcl-xL Inhibition Suppresses Metastasis in Triple-Negative Breast Cancer
por: Skov, Natascha, et al.
Publicado: (2022)

Combined inhibition of EGFR and c-ABL suppresses the growth of triple-negative breast cancer growth through inhibition of HOTAIR
por: Wang, Yuan-Liang, et al.
Publicado: (2015)

Injectable click-crosslinked hydrogel containing resveratrol to improve the therapeutic effect in triple negative breast cancer()
por: Shin, Gi Ru, et al.
Publicado: (2022)

Oxygen Tension Regulates Lysosomal Activation and Receptor Tyrosine Kinase Degradation
por: Hong, Jaewoo, et al.
Publicado: (2019)

A Light‐Triggered Mesenchymal Stem Cell Delivery System for Photoacoustic Imaging and Chemo‐Photothermal Therapy of Triple Negative Breast Cancer
por: Xu, Chang, et al.
Publicado: (2018)

Rab2 promotes autophagic and endocytic lysosomal degradation
por: Lőrincz, Péter, et al.
Publicado: (2017)

Clusterin: a key player in cancer chemoresistance and its inhibition
por: Koltai, Tomas
Publicado: (2014)

Clusterin ameliorates tau pathology in vivo by inhibiting fibril formation
por: Wojtas, Aleksandra M., et al.
Publicado: (2020)

Knockdown of Pyruvate Kinase M Inhibits Cell Growth and Migration by Reducing NF-κB Activity in Triple-Negative Breast Cancer Cells
por: Ma, Chaobing, et al.
Publicado: (2019)

Periodic Mesoporous Organosilica Coated Prussian Blue for MR/PA Dual‐Modal Imaging‐Guided Photothermal‐Chemotherapy of Triple Negative Breast Cancer
por: Tian, Wei, et al.
Publicado: (2016)

ONC201 activates ER stress to inhibit the growth of triple-negative breast cancer cells
por: Yuan, Xun, et al.
Publicado: (2017)

OSW‐1 inhibits tumor growth and metastasis by NFATc2 on triple‐negative breast cancer
por: Ding, Xiaorong, et al.
Publicado: (2020)

GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer
por: Wu, Qin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bfh7olebsu3ehqn84agvj8cj1p